[Risdiplam (spinal muscular atrophy): Review of the study protocol (Version 5.0) and the statistical analysis plan (Version 5.0) – Fourth addendum to Project A21-131 (RPDC concept)]

Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018016123
German
Original Title: Risdiplam (Spinale Muskelatrophie): Prüfung des Studienprotokolls (Version 5.0) und des statistischen Analyseplans (Version 5.0) – 4. Addendum zum Projekt A21-131 (AbD-Konzept)
Details
Project Status: Completed
Year Published: 2026
English language abstract: There is no English language summary available
Publication Type: Full HTA
Country: Germany
MeSH Terms
  • Muscular Atrophy, Spinal
  • Registries
  • Neuromuscular Agents
  • Pyrimidines
  • Azo Compounds
  • Spinal Muscular Atrophies of Childhood
Keywords
  • Risdiplam
  • Muscular Atrophy – Spinal
  • Benefit Assessment
  • Registries
  • Research Design
  • Peer Review – Research
Contact
Organisation Name: Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address: IQWiG, Siegburger Str. 237, 50679 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email: berichte@iqwig.de
Copyright: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.